Peptaris, Inc. has raised $250K in seed funding. The company is using AI and evolutionary intelligence to design peptides.

Get the full Peptaris, Inc. company profile
Access contacts, investors, buying signals & more
Peptaris, Inc. has raised $250K in seed funding. The company is using AI and evolutionary intelligence to design peptides.
This Week’s Health & BioTech Funding Rounds 🚀 Health and BioTech investment is accelerating, driving advancements in precision medicine, AI diagnostics, and next-gen therapeutics. At KenkoTech Futures, we’re tracking the latest funding rounds shaping the future of healthcare.
Here are this week’s key raises: Pepper Auditors (Seed) $1.9M Corridor (Seed) $25M Bioinsights (Seed) $2.75M PrescriptSure, Inc. (Seed) $250K Ambitious Bio (Seed) $6M Peptaris, Inc. (Seed) $250K Apollon (Series A) ₩5B Vasowatch Inc (Seed) $250K Ramona (Series A) $25M Anura Connect (Seed) $1.1M Ema (Series B) $77M Pilgrim (Seed) $25M ParentConnect (Seed) $420K AvenCell (Series C) $6M Basalt Health

Clever Culture Systems
Clever Culture Systems (CCS) is an Australian Biotechnology Company and leader in microbiology technology driven by artificial intelligence. The Company is publicly listed on the Australian Securities Exchange (ASX: CC5). Using artificial intelligence (AI) to deliver automation in microbiology, the company has developed a patent protected machine learning and intelligent imaging platform technology to deliver the only FDA cleared instrument utilising AI technology in microbiology. Our technologies are designed by microbiologists for microbiologists to ensure our products not only meet the needs of the laboratory but also seamlessly integrate within our customer’s workflow. Our team are highly experienced in biotechnology, laboratory automation, diagnostics and microbiology. THE CLEVER WAY TO AUTOMATE PLATE READING The market-leading, innovative technology streamlines busy laboratory workflows, offering a modular approach. The APAS Independence is a stand-alone automated culture plate reading instrument that accurately and efficiently screens and sorts significant and insignificant growth plates at a rate of 200 plates per hour. The modular system ensures you only pay for what you need. Choose from urine, infection control (antibiotic resistance), respiratory and MRSA modules. The innovative, FDA cleared culture plate classification system identifies negative plates, allowing microbiologists to focus on the positive and significant growth plates that require their time and expertise, accelerating patient diagnosis.
$1.8M Unknown
today
Largest funding rounds in Biotechnology on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() Shockwave Medical United States | Unknown | $13.1B | 2y ago |
| 2 | ![]() NeuroEM Therapeutics United States | Unknown |
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() Agro Reply South Africa | Seed | $500.0K | today |
| 2 | ![]() Doorstep United States | Seed | $8.0M | today |

Glampings.com
Glampings.com is a leading online booking platform for glamping accommodations across Europe. It offers over 4,500 verified glamping sites in 17 countries, including treehouses, safari tents, domes, and other unique stays. The company provides a low-price guarantee, real-time availability, and direct booking with providers, positioning itself as the #1 glamping expert with more than 10 years of experience in the European camping and glamping market.
$2.2M Unknown
today
| $7.2B |
| 2y ago |
| 3 | ![]() Illumina United States | Unknown | $7.1B | 2y ago |
| 4 | ![]() GRAIL United States | Unknown | $7.1B | 2y ago |
| 5 | ![]() RemeGen Biosciences United States | Grant | $5.6B | 10mo ago |
| 3 |
![]() Z Creative Partners Co., Ltd. |
| Seed |
| $314.9K |
| today |
| 4 | ![]() 4D Surgical United States | Seed | $8.0M | 2d ago |
| 5 | ![]() Clevoy | Seed | $224.6K | 2d ago |
Trusted by 200+ sales teams
See who invested in Peptaris, Inc. and reach their contacts directly.
Start free trial
Ambitious Bio
Recently received

PrescriptSure, Inc.
Recently received

Bioinsights
Recently received